An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL)

Date

2015

Author

Younes, Anas
Salles, Gilles
Martinelli, Giovanni
Bociek, R. Gregory
Barrigon, Dolores Caballero
Gonzalez Barca, Eva
Kim, Won Seog

Metadata

Show full item record

Abstract

…

Source

Blood

Volume

126

Issue

23

URI

https://hdl.handle.net/20.500.12712/13896

Collections